Evidence map›Paper›PMID 41879595›Full record

ArticleJACC. Case reports2026

Heart Transplantation as Salvage Therapy of Candida tropicalis Prosthetic Aortic Valve Endocarditis.

Sofía Vila-Sanjuán, Marco Tomasino, Álvaro Jara-Díaz, Pau Rello-Sabaté, Albert Roque, Lorena Herrador, Elena García-Romero, Núria Sabé, Marcos Potocnik, Núria Fernández-Hidalgo

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sofía Vila-SanjuánServei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Electronic address: sofiavz77@gmail.com.
Marco TomasinoServei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Álvaro Jara-DíazServei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Pau Rello-SabatéServei de Cardiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Albert RoqueServei de Radiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Lorena HerradorUnitat d'Insuficiència Cardíaca Avançada i Trasplantament, Servei de Cardiologia, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Elena García-RomeroUnitat d'Insuficiència Cardíaca Avançada i Trasplantament, Servei de Cardiologia, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Núria SabéServei de Malalties Infeccioses, Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Spain.
Marcos PotocnikServei de Cirurgia Cardiaca, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Núria Fernández-HidalgoServei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFungal infective endocarditis (IE) is rare but potentially fatal. Heart transplantation (HT) may be considered in selected patients when conventional therapy fails, but indications remain unclear. CASE SUMMARY: A 44-year-old man developed acute heart failure due to Streptococcus agalactiae native valve IE with severe aortic regurgitation, requiring emergent aortic valve replacement. Early prosthetic valve IE due to Candida tropicalis occurred, complicated by recurrent periprosthetic pseudoaneurysms. Extracardiac infection was excluded. HT was successfully performed. No episodes of rejection or recurrence of IE occurred after 2 years of follow-up. DISCUSSION: Although there is little literature on the subject, some cases of HT as salvage treatment for inoperable IE have been reported. HT should be considered an exceptional strategy for highly selected patients. Multidisciplinary decision-making is crucial. TAKE-HOME MESSAGE: In selected patients with inoperable IE, HT may be a therapeutic option, but it should be framed as an exceptional, last-resort intervention.

Indexed as

acute heart failurecardiac transplantendocarditisvalve replacement

Identifiers

PMID41879595
PMCPMC13130899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.